share_log

bluebird bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(1.80%)

bluebird bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

bluebird bio | SC 13G/A：超過5%持股股東披露文件(修正)
SEC announcement ·  04/10 09:57
Moomoo AI 已提取核心訊息
State Street Corporation has filed an amended Schedule 13G with the United States Securities and Exchange Commission (SEC) on March 31, 2024, indicating a change in its holdings of bluebird bio, Inc. common stock. The filing, categorized under Rule 13D-1(B), shows that State Street Corporation has shared voting power over 3,293,844 shares and shared dispositive power over 3,428,135 shares of bluebird bio. This represents a significant stake in the company, as the aggregate amount of shares beneficially owned by State Street Corporation constitutes more than five percent of bluebird bio's class of common stock. The filing asserts that the shares were acquired and are held in the ordinary course of business, not with the intent of changing or influencing the control of the issuer...Show More
State Street Corporation has filed an amended Schedule 13G with the United States Securities and Exchange Commission (SEC) on March 31, 2024, indicating a change in its holdings of bluebird bio, Inc. common stock. The filing, categorized under Rule 13D-1(B), shows that State Street Corporation has shared voting power over 3,293,844 shares and shared dispositive power over 3,428,135 shares of bluebird bio. This represents a significant stake in the company, as the aggregate amount of shares beneficially owned by State Street Corporation constitutes more than five percent of bluebird bio's class of common stock. The filing asserts that the shares were acquired and are held in the ordinary course of business, not with the intent of changing or influencing the control of the issuer, nor in connection with any transaction that has such purpose or effect. The subsidiaries of State Street Corporation listed in the filing as beneficial owners include SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, State Street Global Advisors Limited, and State Street Global Advisors Trust Company, all classified as Investment Advisors (IA).
State Street Corporation已於2024年3月31日向美國證券交易委員會（SEC）提交了經修訂的附表13G，表明其持有的藍鳥生物公司普通股發生了變化。該文件歸類於第13D-1（B）條，顯示道富公司對3,293,844股股票共享投票權，對藍鳥生物的3,428,135股股票共享處置權。這是該公司的重要股份，因爲State Street Corporation實益持有的股份總額佔藍鳥生物普通股類別的5％以上。該文件稱，這些股份是在正常業務過程中收購和持有的，其目的不是改變或影響發行人的控制權，也不是與任何具有此類目的或效果的交易有關。文件中列爲受益所有人的道富公司的子公司包括SSGA基金管理有限公司、道富環球顧問歐洲有限公司、道富環球顧問有限公司和道富環球顧問信託公司，均被歸類爲投資顧問（IA）。
State Street Corporation已於2024年3月31日向美國證券交易委員會（SEC）提交了經修訂的附表13G，表明其持有的藍鳥生物公司普通股發生了變化。該文件歸類於第13D-1（B）條，顯示道富公司對3,293,844股股票共享投票權，對藍鳥生物的3,428,135股股票共享處置權。這是該公司的重要股份，因爲State Street Corporation實益持有的股份總額佔藍鳥生物普通股類別的5％以上。該文件稱，這些股份是在正常業務過程中收購和持有的，其目的不是改變或影響發行人的控制權，也不是與任何具有此類目的或效果的交易有關。文件中列爲受益所有人的道富公司的子公司包括SSGA基金管理有限公司、道富環球顧問歐洲有限公司、道富環球顧問有限公司和道富環球顧問信託公司，均被歸類爲投資顧問（IA）。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息